CDT Equity Inc. has deployed an AI-led drug repurposing strategy for its portfolio and identified a new biological target and novel therapeutic indication for its lead program, AZD-1656 (and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results